Work Here?
Industries
AI & Machine Learning
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
San Francisco, California
Founded
2012
Augmedix uses ambient AI technology to help healthcare providers manage administrative tasks more efficiently. The platform listens to natural conversations between clinicians and patients, transforming these discussions into organized medical notes and useful data. This process not only supports clinical decision-making but also improves the overall efficiency of healthcare operations by providing timely notifications at the point of care. Augmedix serves hospitals and health systems by analyzing data from numerous interactions in different care environments, aiming to enhance clinical, operational, and financial results. Unlike many competitors, Augmedix operates on a subscription model, allowing healthcare providers to access its AI solutions to lessen administrative workloads and improve patient care.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$283M
Above
Industry Average
Funded Over
5 Rounds
Augmedix Awarded Vizient Contract for Ambient AI Documentation Solutions. by Fred Pennic 01/13/2025 Leave a Comment. What You Should Know: – Augmedix, a leader in ambient AI medical documentation and a wholly-owned subsidiary of Commure has secured a contract with Vizient, the nation’s largest provider-driven healthcare performance improvement company. – The agreement grants Vizient’s extensive network of healthcare providers access to Augmedix’s comprehensive suite of AI-powered documentation solutions.Streamlining Documentation with AIVizient serves a vast majority of acute care providers, academic medical centers, and non-acute care facilities across the United States. Its diverse customer base, representing over $140 billion in annual purchasing volume, includes pediatric facilities, community hospitals, and integrated health delivery networks.Through this contract, Vizient members can now leverage Augmedix Go, a cost-effective and scalable AI documentation solution that automatically generates medical notes from natural clinician-patient conversations. This technology empowers providers to:Reduce administrative burden: Freeing up clinicians from time-consuming documentation tasks.Improve operational efficiency: Streamlining workflows and optimizing clinical documentation processes.Enhance clinician and patient experiences: Allowing clinicians to focus more on patient interaction and care delivery.Broad Compatibility and IntegrationAugmedix Go seamlessly integrates with over 50 EHR systems, including Epic, Oracle Health, and MEDITECH, making it a versatile solution for various healthcare settings. This compatibility ensures that providers can easily incorporate Augmedix’s technology into their existing workflows.“We are excited to introduce Vizient’s provider clients to the transformative potential of Ambient Clinical Documentation,” said Ian Shakil, founder of Augmedix and Chief Strategy Officer of Commure
Augmedix Go seamlessly integrates with over 50 EHR systems, including Epic, Oracle Health, and MEDITECH, making it a versatile solution for various healthcare settings.
Augmedix, Inc. will be acquired by Commure, Inc. in an all-cash transaction valued at approximately $139 million. Augmedix stockholders will receive $2.35 per share, a 169% premium over the 30-day VWAP ending July 18, 2024. Augmedix will become a wholly-owned subsidiary of Commure. CEO Manny Krakaris stated that the acquisition will enhance Augmedix's ability to scale and innovate its ambient AI medical documentation solutions.
Commure to Acquire Augmedix in $139M All-Cash Deal by Fred Pennic 07/19/2024 Leave a Comment What You Should Know: – Augmedix (AUGX), a leader in AI-powered medical documentation and data solutions, is being acquired by healthcare technology provider Commure in an all-cash deal valued at approximately $139M. News of the acquisition brought Augmedix up by 150% at $2.27 at 10 am ET after closing at $0.92 on Thursday. – Augmedix leverages AI technology to streamline medical documentation and data management for healthcare providers. Their platform uses ambient AI to convert natural conversations into organized medical notes, improving efficiency and clinical decision-making. – The combined company aims to leverage AI and automation to reduce administrative tasks for healthcare professionals, allowing them to spend more time with patients. This could lead to improved patient outcomes, increased provider satisfaction, and a more efficient healthcare system overall. Terms of the Agreement: Augmedix shareholders will receive $2.35 per share.This represents a premium of 169% over Augmedix’s 30-day stock price average.Commure will acquire all outstanding Augmedix shares.The transaction is expected to close in late Q3 or early Q4 of 2024, subject to shareholder approval and customary closing conditions.Upon closing, Augmedix will become a private subsidiary of Commure and its stock will be delisted
Health tech company Commure to acquire Augmedix in $139M deal as AI scribe competition heats up.
Find jobs on Simplify and start your career today
Discover companies similar to Augmedix
Industries
AI & Machine Learning
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
San Francisco, California
Founded
2012
Find jobs on Simplify and start your career today
Discover companies similar to Augmedix